Yahoo Finance Top Ranked Growth Stocks to Buy for August 15th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 14th:
SYNNEX Corporation (SNX): This provider of business process services, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.
SYNNEX Corporation Price and Consensus
SYNNEX Corporation price-consensus-chart | SYNNEX Corporation Quote
SYNNEX has a PEG ratio 0.56, compared with 1.03 for the industry. The company possesses a Growth Score of A.
SYNNEX Corporation PEG Ratio (TTM)
SYNNEX Corporation peg-ratio-ttm | SYNNEX Corporation Quote
Gildan Activewear Inc. (GIL): This manufacturer of everyday basic apparel, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Gildan Activewear, Inc. Price and Consensus
Gildan Activewear, Inc. price-consensus-chart | Gildan Activewear, Inc. Quote
Gildan has a PEG ratio 1.27, compared with 1.38 for the industry. The company possesses a Growth Score of B.
Gildan Activewear, Inc. PEG Ratio (TTM)
Gildan Activewear, Inc. peg-ratio-ttm | Gildan Activewear, Inc. Quote
Crocs, Inc. (CROX): This retailer of casual footwear for women, men and children, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 days.
Crocs, Inc. Price and Consensus
Crocs, Inc. price-consensus-chart | Crocs, Inc. Quote
Crocs has a PEG ratio 1.14, compared with 1.38 for the industry. The company possesses a Growth Score of A.
Crocs, Inc. PEG Ratio (TTM)
Crocs, Inc. peg-ratio-ttm | Crocs, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SYNNEX Corporation (SNX) : Free Stock Analysis Report
Gildan Activewear, Inc. (GIL) : Free Stock Analysis Report
Crocs, Inc. (CROX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
